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Abstract: Various treatments have been used to change both the topography and chemistry of
titanium surfaces, aiming to enhance tissue response and reduce healing times of endosseous
implants. Most studies to date focused on bone healing around dental implants occurring later
during the healing cascade. However, the impact of the initial inflammatory response in the surgical
wound site on the success and healing time of dental implants is crucial for implant integration and
success, yet it is still poorly understood. The purpose of this study was to investigate the effect
of titanium surface hydrophilicity on the response of human neutrophils by monitoring oxygen
radical production, which was measured as chemiluminescence activity. Materials and Methods:
Neutrophils were isolated from human donors’ blood buffy coats using the double sucrose gradient
method. Neutrophils were exposed to both hydrophilic and hydrophobic titanium surfaces with
identical topographies in the presence and absence of human serum. This resulted in six experimental
groups including two different implant surfaces, with and without exposure to human serum,
and two control groups including an active control with cells alone and a passive control with
no cells. Two samples from each group were fixed and analyzed by SEM. Comparisons between
surface treatments for differences in chemiluminescence values were performed using analysis of
variance ANOVA. Results and Conclusion: In the absence of exposure to serum, there was no
significant difference noted between the reaction of neutrophils to hydrophilic and hydrophobic
surfaces. However, there was a significant reduction in the mean and active chemiluminescence activity
of neutrophils to serum-coated hydrophilic titanium surfaces than to serum-coated hydrophobic
titanium surfaces. This suggests that surface hydrophilicity promotes enhanced adsorption of
serum proteins, which leads to decreased provocation of initial immune cells and reduction of local
oxygen radical production during wound healing. This can help explain the faster osseointegration
demonstrated by hydrophilic titanium implants.
Keywords: hydrophilic; dental implant; biomaterials; titanium; surface chemistry; implant
surface; osseointegration
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1. Introduction
Dental rehabilitation of edentulous or partially edentulous patients with fixed prostheses supported
by titanium implants is well accepted and documented in extended clinical trials [1,2]. The intimate
contact formed between titanium surfaces and bone (osseointegration) has been paramount to the
success of dental implants [3,4]. Consequently, the titanium surface used in dental implants has
been modified over the past few decades in an attempt to accelerate and improve healing outcomes.
Wennerberg and Albrektsson published an extensive review on the subject of surface topographies
of commercially available titanium dental implants and their effect on tissue integration [5]. Surface
roughness (Sa) is classified according to the degree of roughness into four categories: smooth
(Sa = 0.0–0.4 µm), minimally rough (Sa = 0.5–1.0 µm), moderately rough (Sa = 1.0–2.0 µm), and rough
(Sa > 2.0 µm) [6]. Moderately rough surfaces have been shown in a number of in vitro and in vivo
reports to enhance the growth of osteoblasts and increase torque removal forces when compared to
smoother machined surfaces [5,7–10]. Moderately rough surfaces are often hydrophobic and produced
by sandblasting and/or acid etching of the titanium surface. In 2006, a manufacturer introduced
a chemically-modified moderately rough (CMR) and hydrophilic version of their long-established
moderately rough (MR) and hydrophobic surface. Besides being the first hydrophilic titanium surface
for the application of dental implants, the new surface provides less carbon contamination and superior
conditions for direct protein adsorption. In vivo studies demonstrated better clot stabilization at the
early phases of healing, thus resulting in shorter healing and osseointegration times [11–16]. In vitro
studies demonstrated that hydrophilic surfaces promote earlier activation of the regenerative M2
macrophage response [17–20]. Furthermore, osteoblasts demonstrated increased osteocalcin and
local growth factor production when exposed to hydrophilic titanium surfaces when compared to
hydrophobic surfaces [21]. Consequently, clinical recommendations for shorter loading protocols were
adjusted to be at three to four weeks instead of the standard six to eight weeks. This resulted in a
significantly reduced implant therapy time [22,23].
One of the possible factors contributing to reduced healing times with hydrophilic surfaces is the
reaction of the initial inflammatory cells populating the implant surface immediately after being placed in
the surgically prepared osteotomy site. Ivanovski et al. demonstrated that inflammation is a key biological
mechanism, tightly regulated during early wound healing, which impacts osseointegration and guided
bone regeneration [24]. The impact of the initial inflammatory response on the healing time and the
osseointegration of endosteal implants is potentially crucial to rapid healing but is still poorly understood.
The primary cellular response in inflammation comes from the polymorphonuclear leukocytes (PMNs),
which include neutrophils, basophils, and eosinophils. Neutrophils are the first line of defense and
are immediately present in any bleeding wound. These cells constitute 40–65% of the white blood cell
population and are responsible for releasing cytotoxic products that are essential for killing bacterial
invaders, but these same molecules can also destroy host tissues. Within seconds after stimulation,
phagocytes show a sharp increase in oxygen uptake and begin to release large quantities of reactive
oxygen metabolites. These include singlet oxygen, superoxide, hydrogen peroxide, and hydroxyl radicals.
When these toxic oxygen metabolites are released, one consequence of this respiratory burst is
that light is emitted [25,26]. In 1974, Allen et al. discovered that activated neutrophils could generate
light known as chemiluminescence (CL), and this forms the basis for an extremely sensitive assay that
can measure reactive oxidant production by a small number of neutrophils [27]. Neutrophil CL can
be detected in as little as 5 µL of unfractionated human blood [28]. Consequently, a specific range of
neutrophil priming and activation to an implanted biomaterial is essential for a proper wound healing
cascade and ultimate implant tissue integration. However, an exaggerated respiratory burst-centered
reaction with the associated released oxygen radicals might lead to local tissue damage and delayed
wound healing.
The purpose of this in vitro study was to investigate the response of human neutrophils to
a hydrophobic sandblasted acid etched surface (MR) and to a chemically-modified, sandblasted,
and acid-etched surface (CMR) by monitoring their chemiluminescence (CL) activity.
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2. Materials and Methods
Blood buffy coats were received from Indiana Blood Center (IBC) in Indianapolis, IN, USA.
Institutional Review Board approval from Indiana University School of Medicine was granted
(approval number NS0806-02). Buffy coats were then diluted 1:1 with Roswell Park Memorial Institute
(RPMI) cell media to maximize the efficiency of separation. Neutrophils were isolated from blood
buffy coats using the double dextran gradient method described by Kowolik et al. [29,30]. Cells were
then counted under a hemocytometer using the trypan blue exclusion test. Cell viability was 99% for
all samples.
MR and CMR treated discs were supplied by the same implant company (Straumann AG, Basel,
Switzerland). Four groups were comprised of two different implant surfaces with or without exposure
of discs to human serum. Two control groups included an active control with cells alone (no discs) and
a passive control with reagents alone.
This resulted in a total of 6 groups as follows:
(1) Reagents alone (n = 24)
(2) Cells alone (n = 24)
(3) Cells + MR discs (n = 24)
(4) Cells + CMR discs (n = 24)
(5) Cells + MR discs after exposure to human serum for 30 min (n = 24)
(6) Cells + CMR discs after exposure to human serum for 30 min (n = 24)
Chemiluminescence Reaction Measurement
CL assays were performed according to established protocols for human neutrophils with a
chemiluminometer [31]. Titanium discs were placed in the base of a polystyrene reaction cuvette in
300 µL sterile phosphate buffer saline (PBS) and 500 µL of a neutrophil suspension containing
500,000 cells was added. In 2 treatment groups, the discs were immersed in human serum
obtained during the isolation method (homologous to the cells) for 30 min before placing them in
cuvettes. We added 100 µL of 1× 10−6 luminol at time zero and, after 30 min, 1× 10−6 M of the stimulant
phorbol myristate acetate (PMA) was added. The total reaction volume was 1.0 mL. The reaction
was followed for a further 60 min. The CL assays were performed in a 1251 Bio-Orbit Luminometer
(Bio-Orbit, Turku, Finland). Cellular activation was recorded in millivoltages, the integrals calculated,
and data analysis was performed on the mean values of triplicate experiments.
Chemiluminescence data from each experimental were divided by the control to standardize the
data from different experimental runs. The CL values were summarized (mean, standard deviation,
standard error, minimum, and maximum) for each group. Statistical significance was assessed using
analysis of variance (ANOVA). CL data were summarized for each surface type and serum presence
combination. The effects of surface type and serum presence were assessed. The ANOVA included
terms for surface type, serum presence, type-by-serum presence interaction, and a random effect for
experimental run. A p-value of <0.05 was considered significant. For post-hoc testing, the Tukey method
was used for comparing all possible group pairings. Two samples of each group were immediately
fixed in 5% glutaraldehyde for scanning electron microscopic (SEM, Thermo Fisher Scientific, Waltham,
MA, USA) analysis. Samples were dehydrated through a graded series of ethanol, chemically dried in
Hexamethyldisilazane (HMDS), attached to aluminum with epoxy for examination, sputter coated
with 60/40 gold/palladium alloy, and examined at 25 kV by scanning electron microscopy.
3. Results
3.1. Chemiluminescence Activity
Chemiluminescence measurements were used to quantify the oxidative burst by neutrophils
(Table 1). Each experimental cycle resulted in three chemiluminescence measurements:
Active CL (active CL): representing the area under the CL curve, which is the integrated energy output
over the 90 min total reaction period.
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Mean CL (mean CL): representing the mean value of CL during the experimental run.
Peak CL (peak CL): representing the highest reading during the experimental run.
In the absence of serum coatings, MR and CMR discs did not have significantly different active CL
(p = 0.35), mean CL (p = 0.29), or peak CL (p = 0.42). Serum-coated CMR discs provoked significantly
less active CL (5926.227) and Mean CL (0.987) in the CMR group when compared to the Active CL
(7322.863) and Mean CL (2.392) values in the serum-coated discs in the MR group. These differences
were statistically significant (p < 0.05) (Figures 1 and 2). No significant differences were found in peak
chemiluminescence in any of the experimental and positive control groups (p > 0.05) (Figure 3).
Materials 2020, 13, x FOR PEER REVIEW 4 of 8 
 
Active CL (active CL): representing the area under the CL curve, which is the integrated energy 
output over the 90 min total reaction period. 
Mean CL (mean CL): representing the mean value of CL during the experimental run. 
Peak CL (peak CL): representing the highest reading during the experimental run. 
In the absence of serum coatings, MR and CMR discs did not have significantly different active 
CL (p = 0.35), mean CL (p = 0.29), or peak CL (p = 0.42). Serum-coated CMR discs provoked 
significantly less active CL (5926.227) and Mean CL (0.987) in the CMR group when compared to the 
Active CL (7322.863) and Mean CL (2.392) values in the serum-coated discs in the MR group. These 
differences were statistically significant (p < 0.05) (Figures 1 and 2). No significant differences were 
found in peak chemiluminescence in any of the experimental and positive control groups (p > 0.05) 
(Figure 3). 
 
Figure 1. Active chemiluminescence. 
 
Figure 2. Mean chemiluminescence. 
 
Figure 3. Peak chemiluminescence. 
Figure 1. Active chemiluminescence.
Materials 2020, 13, x FOR PEER REVIEW 4 of 8 
 
Active CL (active CL): representing the area under the CL curve, which is the integrated energy 
output over the 90 min total reaction period. 
Mean CL (mean CL): representing the mean value of CL during the experimental run. 
Peak CL (peak CL): representing the highest reading during the experimental run. 
In the absence of serum coatings, MR and CMR discs did not have significantly different active 
CL (p = 0.35), mean CL (p = 0.29), or peak CL (p = 0.42). Serum-coated CMR discs provoked 
significantly less active CL (5926.227) and Mean CL (0.987) in the CMR group when compared to the 
Active CL (7322.863) and Mean CL (2.392) values in the serum-coated discs in the MR group. These 
differences were statistically significant (p < 0.05) (Figures 1 and 2). No significant differences were 
found in peak chemiluminescence in any of the experimental and positive control groups (p > 0.05) 
(Figure 3). 
 
Figure 1. Active chemiluminescence. 
 
Figure 2. Mean chemiluminescence. 
 
Figure 3. Peak chemiluminescence. 
Figure 2. ean che ilu inescence.
Materials 2020, 13, x FOR PEER REVIEW 4 of 8 
 
Active CL (active CL): representing the area under the CL curve, which is the integrated energy
ou put o er the 90 min total reaction period. 
Mean CL (mean CL): representing the mean value of CL during the experimental run. 
Peak CL (peak CL): representing the highest reading during the exp rimental run. 
In the absence of serum coati gs, MR and CMR iscs did o  ave significantly different active 
CL (p = 0.35), m an CL (  = 0.29), or peak L (p = 0.42). Serum-coated CMR discs provoked 
significantly less active CL (5926.227) and Mean CL (0.987) in the CMR group when compared t  the 
Active CL (7322.863) and Mean CL (2.392) values in the serum-coated discs in t  MR group. Thes  
differ nces were statistically significant (p < 0.05) (Figures 1 and 2). No sign ficant diffe ences w r  
found in peak chemiluminescence n any of the experim ntal and positive control groups (  > 0.05) 
(Figure 3). 
 
Figure 1. Active chemiluminescence. 
 
Figure 2. Mean chemiluminescence. 
 
Figure 3. Peak chemiluminescence. 
Figure 3. Peak chemiluminescence.
Materials 2020, 13, 3421 5 of 8
Table 1. Mean chemiluminescence (CL) values.
CL
Measurement
Reagents
(n = 24)
Cells Alone
(n = 24)
Cells +MR
(n = 24)
Cells +
CMR
(n = 24)
Cells +MR
+ Serum
(n = 24)
Cells + CMR +
Serum
(n = 24)
Active CL 2445.349 SD(±24)
7067.98 SD
(±121)
8728.43 SD
(±1002)
7625.99 SD
(±932)
7322.86 SD
(±721)
5926.23 SD
(±620)
Mean CL 0.45 SD(±0.038)
1.36 SD
(±0.125)
1.263 SD
(±0.131)
1.212 SD
(±0.118)
2.392 SD
(±0.25) 0.978 SD (±0.87)
Peak CL 0.47 SD(±0.13)
2.837 SD
(±0.92)
2.791 SD
(±0.89)
3.331 SD
(±0.9)
3.142 SD
(±0.81) 2.969 SD (±0.68)
3.2. SEM Imaging
Neutrophil activation: SEM photomicrographs following 60-min incubation and immediately
following stimulation with PMA (Figure 4).
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4. Discussion
Davies et al. opined that by the time osseointegration occurs, most of the critical events in healing
around dental implants have taken place [32]. The trend toward immediate and early loading of dental
implants makes it prudent to understand the early healing events around the endosteal implants
immediately after insertion. This understanding will help guide future research of implant surfaces and
biomaterials that demonst ate faster healing and integration times. The pri ary stage in wound healing
after the surgical placement of biomaterials is an inflamm tory response. This injury and the subsequent
perturbation of the homeostatic mechanis s trigger cellular cascades of wound healing. Therefore,
initial inflammatory responses to endosseous titanium implants are thought to play a crucial role in
forming and maintaining osseointegration, and thereby clinical success. This response is dependent
on multiple factors including the extent of the injury, blood–material interactions, provisional matrix
formation, the extent or degree of cellular necrosis, and the extent of the inflammatory response. The
response of human neutrophils, the initial inflammatory cells populating the implant surface, may
play a fundamental role in the early phases of wound healing. The level of neutrophil priming and
activation may be linked to the rate and type of healing following implant lace ent, as well as
the long-t rm stability of the rigid bone–implant interface. In thi cont xt, we at empted to test the
response of human neutrophils to a hydrophilic microrough surface against a topogra hically identical
hydrophobic microrough surface coated with homologous serum. The research team hypothesized that
a difference in the initial inflammatory response could be at least in part responsible for this superior
healing quality, previously demonstrated in in vivo trials [13,14] by influencing the trajectory of the
wound healing cascade. The results suggested that the explanation behind clinically-observed healing
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superiority of the CMR surface implants might begin at the response of initial inflammatory cells
coming into contact with the implant surface. In this study, neutrophils exposed to the serum-coated
hydrophilic CMR surfaces produced less harmful oxygen radicals compared with neutrophils exposed
to hydrophobic MR surfaces. A limitation of the current investigation is that no attempt was made
to identify or quantify the types and nature of serum proteins attachment to the surface. Previous
investigations demonstrated that the neutrophil recognition and response to biomaterials can be
significantly influenced by the nature of the protein layer that coats the biomaterial surface immediately
after implantation [33–35]. The biomaterial surface characteristics may directly influence the attraction
and binding of serum proteins as well as affect the presentation manner of the adsorbed protein to
inflammatory cells. The predominating proteins that bind to implanted biomaterials are IGg, albumin,
and fibrinogen [36]. Polymer surfaces coated with human serum albumin (HSA) and fibrinogen
were shown to markedly decrease neutrophil activation [35,37]. Similarly, adsorption of IGg activates
complement [38,39], which, in turn, can stimulate neutrophil activation [40,41]. To the best of our
knowledge, this is the first study to look at the neutrophil reaction to commercially available hydrophilic
and hydrophobic titanium surfaces with the same surface topography. Within the limitations of this
in vitro study, we found a significant difference in the reaction of human neutrophils to a serum-coated
chemically-modified hydrophilic surface compared to a hydrophobic surface with the same surface
topography. We theorize that hydrophilic surfaces are capable of faster and more favorable selective
adsorption of serum proteins, which can downregulate the activation of neutrophils causing less
production of oxygen radicals and tissue destruction. Further studies are needed to understand more
about the type and the role that adsorbed proteins play on titanium surfaces, as well as to better
understand the initial inflammatory response around implants and its impact on healing.
5. Conclusions
The reaction of neutrophils to MR and CMR surfaces suggests that these surfaces, overall, provoke
minimal reaction from human inflammatory cells, which could be favorable during the healing period
leading to osseointegration. In the absence of exposure to serum, there were no significant differences
found between hydrophilic and hydrophobic surfaces. However, after exposing both surfaces to human
serum, we found was a statistically significant reduction in respiratory-burst activity by neutrophils
exposed to the hydrophilic surface, suggesting a more favorable environment during the initial healing
period. The results suggested that hydrophilic biomaterial surfaces might promote a more favorable
initial inflammatory host response and that this response might help promote faster integration of
endosseous implanted biomaterials.
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